硬皮病患者的麻醉管理1例并文献复习
Anesthesia Management in Patients with Scleroderma: A Case Report
DOI: 10.12677/ACM.2021.115298, PDF,   
作者: 张禄露, 魏亚囡：西安医学院，陕西 西安；高子军, 董补怀*：西安市红会医院麻醉科，陕西 西安
关键词: 硬皮病；生命体征监测；Allen试验；Scleroderma； Vital Signs Monitoring； Allen Test
摘要: 硬皮病是一种罕见疾病，目前为止，其发病原因未知。当这一类患者须进行手术麻醉时，我们的麻醉方案应依据患者硬皮病的疾病特征及个体化进行调整。有创血压监测仍然是硬皮病患者术中最佳的循环监测方式。回顾分析1例行“右乳肿瘤切除术”的患有硬皮病30年的中年女性的整个围术期麻醉管理方法，希望能给同行们在此类罕见病患者的麻醉管理中提供一些有用信息。
Abstract: Scleroderma is a rare disease. So far, the cause of the disease is unknown. When surgical anesthesia is required for this type of patients, our anesthesia plan should be adjusted according to the disease characteristics and individual characteristics of the patients with scleroderma. Invasive blood pressure monitoring is still the best circulatory monitoring method in patients with scleroderma. The entire perioperative anesthesia management of a female middle-aged patient with scleroderma for 30 years who underwent right breast tumor resection was retrospectively analyzed. It is hoped to provide some useful information for the anesthesia management of patients with this rare disease.
文章引用：张禄露, 高子军, 董补怀, 魏亚囡. 硬皮病患者的麻醉管理1例并文献复习[J]. 临床医学进展, 2021, 11(5): 2081-2087. https://doi.org/10.12677/ACM.2021.115298

参考文献

[1] Kucharz, E.J. and Kopeć-Mędrek, M. (2017) Systemic Sclerosis Sine Scleroderma. Advances in Clinical and Experimental Medicine, 26, 875-880. [Google Scholar] [CrossRef] [PubMed]
[2] Beldner, S., Rabinovich, R.V. and Polatsch, D.B. (2020) Scleroderma of the Hand: Evaluation and Treatment. The Journal of the American Academy of Orthopaedic Surgeons, 28, e686-e695.
[3] Orteu, C.H., Ong, V.H. and Denton, C.P. (2020) Scleroderma Mimics—Clinical Features and Management. Best Practice & Research: Clinical Rheumatology, 34, 101489. [Google Scholar] [CrossRef] [PubMed]
[4] Deshayes, S., de Boysson, H. and Geffray, L. (2016) Les syndromes sclérodermiformes [Scleroderma-Like Disorders]. La Revue de Médecine Interne, 37, 616-624. [Google Scholar] [CrossRef] [PubMed]
[5] Asano, Y., Fujimoto, M., Ishikawa, O., Sato, S., Jinnin, M., Takehara, K., Hasegawa, M., Yamamoto, T. and Ihn, H. (2018) Diagnostic Criteria, Severity Classification and Guidelines of Localized Scleroderma. The Journal of Dermatology, 45, 755-780. [Google Scholar] [CrossRef] [PubMed]
[6] Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C.P., Rudnicka, L., Frasin, L.A., Smith, V., Gabrielli, A., Aberer, E., Bagot, M., Bali, G., Bouaziz, J., Braae Olesen, A., Foeldvari, I., Frances, C., Jalili, A., Just, U., Kähäri, V., Kárpáti, S., Kofoed, K., Krasowska, D., Olszewska, M., Orteu, C., Panelius, J., Parodi, A., Petit, A., Quaglino, P., Ranki, A., Sanchez Schmidt, J.M., Seneschal, J., Skrok, A., Sticherling, M., Sunderkötter, C., Taieb, A., Tanew, A., Wolf, P., Worm, M., Wutte, N.J. and Krieg, T. (2017) European Dermatology Forum S1-Guideline on the Diagnosis and Treatment of Sclerosing Diseases of the Skin, Part 1: Localized Scleroderma, Systemic Sclerosis and Overlap Syndromes. Journal of the European Academy of Dermatology and Venereology, 31, 1401-1424. [Google Scholar] [CrossRef] [PubMed]
[7] Luo, Y. and Xiao, R. (2020) The Epigenetic Regulation of Scleroderma and Its Clinical Application. Advances in Experimental Medicine and Biology, 1253, 375-403. [Google Scholar] [CrossRef] [PubMed]
[8] Tsou, P.S. (2019) Epigenetic Control of Scleroderma: Current Knowledge and Future Perspectives. Current Rheumatology Reports, 21, 69. [Google Scholar] [CrossRef] [PubMed]
[9] Moinzadeh, P., Kreuter, A., Krieg, T. and Hunzelmann, N. (2018) Morphea/Lokalisierte Sklerodermie und extragenitaler Lichen sclerosus [Morphea or Localized Scleroderma and Extragenital Lichen Sclerosus]. Der Hautarzt, 69, 892-900. [Google Scholar] [CrossRef] [PubMed]

为你推荐